With obesity or lipedema, there are some specific considerations:
Both conditions (obesity and lipedema) primarily affect fat tissue. However, when the sensor is placed correctly, glucose measurement is usually not directly impacted. Nevertheless, certain factors should be taken into account:

Tissue Changes:

CGM sensors measure glucose in subcutaneous tissue. In lipedema, there is an increased accumulation of fat, particularly in the legs and arms. This altered tissue structure in severely affected areas could slightly affect accuracy.

Blood Flow & Lymphatic Circulation:

In advanced stages of lipedema, blood circulation may be restricted.
Reduced microcirculation could, in rare cases, influence glucose uptake in the tissue and lead to slightly delayed readings.

Sensor Placement:

If a person with obesity or lipedema has very sensitive or hardened skin areas, it may be beneficial to choose alternative sensor placement sites.

➡️ Lipedema and obesity generally do not have a significant impact on CGM measurements. If there are any uncertainties, consulting a healthcare professional is recommended.